Lien De Beck (L De Beck)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Fluorescence Imaging

Multiple Myeloma

Top Venues

EJNMMI research

Molecular cancer therapeutics

Vrije Universiteit Brussel Faculteit Geneeskunde en Farmacie

Vrije Universiteit Brussel Faculteit Geneeskunde en Farmacie (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vrije Universiteit Brussel Faculteit Geneeskunde en Farmacie Oct 01 2017

Belgium

PhD student at Laboratory of Hematology and Immunology / Laboratory of Molecular and Cellular Therapies :: Faculteit Geneeskunde en Farmacie

Education History

Vrije Universiteit Brussel Faculteit Geneeskunde en Farmacie Sep 20 2015 - Jun 02 2017

Belgium

MSC :: Faculteit Geneeskunde en Farmacie

Vrije Universiteit Brussel Faculteit Geneeskunde en Farmacie Sep 20 2012 - Jun 02 2015

Belgium

BSC :: Faculteit Geneeskunde en Farmacie

Publications

Thomas Ertveldt, Lien De Beck, Kirsten De Ridder, Hanne Locy, Wout de Mey, Cleo Goyvaerts, Quentin Lecocq, Hannelore Ceuppens, Yannick De De Vlaeminck, Robin Maximilian Awad, Marleen Keyaerts, Nick Devoogdt, Matthias D'Huyvetter, Karine Breckpot, Ahmet Krasniqi
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model. Molecular cancer therapeutics 21 (7) (2022)
Quentin Lecocq, Pieterjan Debie, Janik Puttemans, Robin Maximilian Awad, Lien De Beck, Thomas Ertveldt, Yannick De De Vlaeminck, Cleo Goyvaerts, Geert Raes, Marleen Keyaerts, Karine Breckpot, Nick Devoogdt
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer. EJNMMI research 11 (1) (2021)
Lien De Beck, Sarah Melhaoui, Kim De Veirman, Eline Menu, Elke De Bruyne, Karin Vanderkerken, Karine Breckpot, Ken Maes
Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects. Oncoimmunology 7 (10) (2018)